Erica Gage Ekerson, in Aberdeen, VA - Counselor

Erica Gage Ekerson, is a Counselor based in Aberdeen, Virginia. Erica Gage Ekerson is licensed to practice in * (Not Available) (license number ) and her current practice location is 244 E Wishkah, Aberdeen, Virginia. She can be reached at her office (for appointments etc.) via phone at (360) 819-3007.

NPI number for Erica Gage Ekerson is 1982183448 and her current mailing address is 244 E Wishkah, Aberdeen, Virginia. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1982183448.

Contact Information

	Erica Gage Ekerson,
	244 E Wishkah, Aberdeen, VA 98550
	(360) 819-3007
	(360) 532-0577

Healthcare Provider's Profile

Full Name	Erica Gage Ekerson
Gender	Female
Speciality	Counselor
Location	244 E Wishkah, Aberdeen, Virginia
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1982183448
Provider Enumeration Date: 08/07/2018
Last Update Date: 03/28/2019

Medical Identifiers

Medical identifiers for Erica Gage Ekerson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1982183448	NPI	-	NPPES
EEKERSON	Medicaid	WA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
101Y00000X	Counselor	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Erica Gage Ekerson is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Erica Gage Ekerson, 244 E Wishkah, Aberdeen, VA 98550 Ph: (360) 819-3007	Erica Gage Ekerson, 244 E Wishkah, Aberdeen, VA 98550 Ph: (360) 819-3007

News Archive

Taking strong anticholinergic doubles risk of developing cognitive impairment in older adults

Research from the Regenstrief Institute, the Indiana University Center for Aging Research and Wishard-Eskenazi Health on medications commonly taken by older adults has found that drugs with strong anticholinergic effects cause cognitive impairment when taken continuously for as few as 60 days.

GNC underwriters exercise option to purchase additional 3.375 million shares

GNC Acquisition Holdings Inc. announced that, in connection with its previously announced initial public offering, the underwriters have exercised in full their option to purchase from the selling stockholders an additional 3.375 million shares of Class A common stock.

Children's Hospital Los Angeles ranked among nation's top 5 again

For the third straight year, Children's Hospital Los Angeles is ranked among the top five children's hospitals in the country, a distinction that recognizes the hospital's clinical expertise and the quality and breadth of its patient care.

Research identifies early biomarker for insulin resistance, glucose intolerance in nondiabetic population

Metabolon, Inc., the leader in metabolomics-based biomarker discovery and analysis, today announced the publication of research that identified a novel, early biomarker for insulin resistance and glucose intolerance in a nondiabetic population.

Erica Gage Ekerson, - Counselor in Aberdeen, VA